Stephen P. Squinto, EVP, Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 36,499 shares at $99.51 ($3.6M) on 2013-04-29, disclosed to the SEC on 2013-05-01.
Scheduled sale ($3.6M) by EVP, Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.96 | 36,299 | $3.6M | 99.4% |
| 2 | $99.51 | 200 | $20K | 0.6% |
| Total | $98.96 avg | 36,499 | $3.6M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |